4 Midcap Five Year Stocks to Watch for Future Multibagger Potential: NALCO, Hindustan Copper, Ajanta Pharma and Nuvama

Five year stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. NALCO, Hindustan Copper, Ajanta Pharma and Nuvama meet that test, with market caps from Rs 31,681 crore to Rs 58,974 crore and NALCO offering the lowest PE of the group at 8.74. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a return on equity above 15 per cent, a PE ratio below 40 and a positive one-year return, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a return on equity above 15 per cent, a PE ratio below 40 and a positive one-year return, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening five year stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 23 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Five Year Stocks and Why Do They Attract Multibagger Interest?

Five year stocks are shares of mid sized companies with strong returns, moderate valuation and rising prices, which suits a five-year holding period. The four here cover aluminium, pharmaceuticals, copper and wealth management.

A five-year horizon gives earnings time to compound and smooths out short-term swings. For five year stocks, both FY26 and the latest quarter showed growth. For five year stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of five year stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for five year stocks before you decide.

Five Year Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 23 October 2026. NALCO has the lowest PE of the group at 8.74, while Hindustan Copper posts the highest return on equity at 27.48%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
National Aluminium Company	301.75	58,974	8.74	12.46	26.83%	2.73	222.71 to 445.15
Hindustan Copper	399.05	43,821	38.57	12.27	27.48%	13.11	308.50 to 760.05
Ajanta Pharma	3,283.90	41,525	36.59	36.35	23.33%	9.17	2,380.20 to 3,796.00
Nuvama Wealth Management	1,661.90	31,681	29.28	33.31	25.26%	7.72	1,096.90 to 2,066.00

NALCO: Return on Equity of 26.83%

National Aluminium Company is a government-owned, integrated bauxite-to-aluminium producer with operations in Odisha. It reported FY26 revenue of Rs 18,508.88 crore, up 7.96% year on year, and net profit of Rs 5,797.01 crore, up 10.04%. Net profit has compounded at 18.38% a year since FY22, while revenue has grown 6.33% a year. Operating margin was 48.16% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 39.31% to Rs 5,475.68 crore and net profit grew 90.87% to Rs 2,003.14 crore. The share price has gained 160.35% over five years and 39.86% over the past year. Foreign investors raised their holding from 15.06% in June 2025 to 21.99% in June 2026. The stock trades at a PE of 8.74 against an industry PE of 12.46, below the sector average, with a return on equity of 26.83%. The dividend yield is 3.58%.

Hindustan Copper: 25.25% Profit CAGR Since FY22

Hindustan Copper is a government-owned company that mines copper ore and produces refined copper in India. It reported FY26 revenue of Rs 3,149.67 crore, up 46.62% year on year, and net profit of Rs 920.66 crore, up 96.97%. Net profit has compounded at 25.25% a year since FY22, while revenue has grown 13.89% a year. Operating margin was 46.74% in FY26. The debt-to-equity ratio is 0.03, which keeps interest costs low.

The stock trades at a PE of 38.57 against an industry PE of 12.27, with a return on equity of 27.48%. In the June 2026 quarter, revenue rose 81.07% to Rs 953.60 crore and net profit grew 162.59% to Rs 352.61 crore. The share price has gained 205.23% over five years and 33.08% over the past year. Foreign investors raised their holding from 3.71% in June 2025 to 5.96% in June 2026.

Ajanta Pharma: Return on Equity of 23.33%

Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026. The stock trades at a PE of 36.59 against an industry PE of 36.35, with a return on equity of 23.33%.

Nuvama: Return on Equity of 25.26%

Nuvama Wealth Management offers wealth management, asset services and capital markets services to affluent clients and institutions. It reported FY26 revenue of Rs 4,649.65 crore, up 11.52% year on year, and net profit of Rs 1,040.26 crore, up 5.60%. Revenue has compounded at 27.07% a year since FY22. Operating margin was 53.05% in FY26.

The stock trades at a PE of 29.28 against an industry PE of 33.31, below the sector average, with a return on equity of 25.26%. The dividend yield is 1.60%. In the June 2026 quarter, revenue rose 22.88% to Rs 1,381.96 crore and net profit grew 15.83% to Rs 305.64 crore. The share price is up 19.71% over the past year. Domestic institutions raised their holding from 6.37% in June 2025 to 8.49% in June 2026.

Five Year Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these five year stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Operating Margin (Latest Quarter)
NALCO	18,508.88	5,797.01	7.96%	6.33%	18.38%	54.34%
Hindustan Copper	3,149.67	920.66	46.62%	13.89%	25.25%	56.02%
Ajanta Pharma	5,624.93	1,056	18.60%	12.94%	10.33%	30.41%
Nuvama	4,649.65	1,040.26	11.52%	27.07%	4.96%	53.22%

Check the Univest Screener for live data on these five year stocks

Institutional Holding in NALCO, Hindustan Copper, Ajanta Pharma and Nuvama

Institutional holding shows who is backing these five year stocks alongside the promoter. The table uses the latest reported quarter for each. NALCO has the deepest institutional backing, with FII and DII together holding 33.21% as of June 2026. Domestic institutions increased their holding over the past year in Ajanta Pharma (from 17.90% to 21.94%) and Nuvama (from 6.37% to 8.49%).

Stock	Promoter	FII	DII	Public	Quarter
NALCO	51.28%	21.99%	11.22%	15.51%	June 2026
Hindustan Copper	66.14%	5.96%	4.84%	23.06%	June 2026
Ajanta Pharma	63.47%	7.63%	21.94%	6.96%	September 2026
Nuvama	53.98%	19.00%	8.49%	18.53%	June 2026

Risks to Weigh in Five Year Stocks

Being careful with five year stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Hindustan Copper trades at a PE of 38.57 against an industry PE of 12.27, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Five Year Stocks

Picking from five year stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.27 to 36.35) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track NALCO, Hindustan Copper, Ajanta Pharma and Nuvama live prices.

Conclusion

Among five year stocks, NALCO stands out for the lowest PE of the group at 8.74, Hindustan Copper for the highest return on equity at 27.48%, Ajanta Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06 and Nuvama for 11.52% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing five year stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Five Year Stocks to Watch

Which are the best five year stocks to watch for multibagger potential?

Ans. NALCO, Hindustan Copper, Ajanta Pharma and Nuvama are the 4 names this list highlights, with market caps of Rs 58,974 crore, Rs 43,821 crore, Rs 41,525 crore and Rs 31,681 crore respectively. NALCO is notable for the lowest PE of the group at 8.74. Hindustan Copper stands out for the highest return on equity at 27.48%. Ajanta Pharma offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Nuvama brings 11.52% revenue growth in FY26. These are watchlist names for five year stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Hindustan Copper a good stock for long-term investors?

Ans. Hindustan Copper has a return on equity of 27.48%, a PE of 38.57 against an industry PE of 12.27 and a market cap of Rs 43,821 crore. Net profit has compounded at 25.25% a year since FY22, and FY26 revenue rose 46.62% while June 2026 quarter net profit grew 162.59%. Long-term returns in five year stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can NALCO become a multibagger from here?

Ans. NALCO has already gained 160.35% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in five year stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 18.38% a year since FY22, and FY26 revenue rose 7.96%. At a PE of 8.74 against an industry PE of 12.46, valuation should be checked against that growth before investing.

What is the market cap of NALCO, Hindustan Copper, Ajanta Pharma and Nuvama?

Ans. As of 23 October 2026, NALCO has a market cap of Rs 58,974 crore, Hindustan Copper has a market cap of Rs 43,821 crore, Ajanta Pharma has a market cap of Rs 41,525 crore and Nuvama has a market cap of Rs 31,681 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on five year stocks.

What are the risks of investing in five year stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Hindustan Copper trades at a PE of 38.57 against an industry PE of 12.27, so earnings growth needs to hold up.

Why is Hindustan Copper trading at a PE of 38.57?

Ans. Hindustan Copper's PE of 38.57 compares with an industry PE of 12.27. The market is paying a premium for a return on equity of 27.48%, profit growth of 25.25% a year since FY22 and latest-quarter profit growth of 162.59%, which also means the stock is more sensitive if growth slows. Investors in five year stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in NALCO, Hindustan Copper, Ajanta Pharma and Nuvama?

Ans. As of the latest reported quarter, FII and DII together hold 33.21% of NALCO (21.99% and 11.22%), 10.80% of Hindustan Copper (5.96% and 4.84%), 29.57% of Ajanta Pharma (7.63% and 21.94%) and 27.49% of Nuvama (19.00% and 8.49%). Rising institutional holding is a useful signal in five year stocks, though it should be read with earnings trends rather than on its own.